Home › Blog › HCP Healthcare Data
HCP Healthcare Data

Is It Legal to Buy Healthcare Professional Email Lists?

HCP Healthcare Data · Gautam · September 28, 2026 · 8 min read · Reviewed Oct 2026

Yes, buying a healthcare professional email list is legal in the United States. The common fear -- that HIPAA makes it illegal -- is a misreading of what HIPAA actually covers. HIPAA protects patient health information. It does not protect a physician's work email address, NPI number, or hospital affiliation. Those are professional contact details, and buying them for B2B marketing purposes is governed by a different set of rules entirely.

This page explains what the law actually says, which rules apply to HCP email marketing, and what you need to do before you send to a purchased list.

What does HIPAA actually cover when it comes to HCP contact data?

HIPAA applies to covered entities -- hospitals, health plans, and healthcare clearinghouses -- and to their business associates who handle protected health information (PHI) on their behalf. PHI is health information tied to an identifiable patient: diagnoses, prescriptions, lab results, treatment records.

A physician's professional contact information is not PHI. Their work email, NPI number, specialty, office address, and hospital affiliation describe the provider, not a patient. When a pharma company, medical device company, or B2B data vendor compiles a list of physician contacts from professional sources -- medical licensing boards, the CMS NPI registry, hospital directories -- they are not handling PHI. HIPAA does not apply to that transaction.

The practical test: Ask whether the data describes a patient's health condition linked to that patient. If it describes a licensed provider's professional role -- their specialty, their employer, their contact details -- HIPAA does not govern its purchase or use for marketing.

Where HIPAA does become relevant: if a hospital sells or shares patient data as part of a marketing arrangement, that would require a valid authorization. But that scenario has nothing to do with purchasing a standard HCP contact list from a data provider.

Which laws actually govern buying and using HCP email lists?

The rules that actually apply to HCP email marketing in the US are:

Does CAN-SPAM apply when you email healthcare professionals?

Yes. CAN-SPAM is the primary federal law governing commercial email in the United States, and it applies to B2B email including outreach to physicians, nurses, and healthcare executives. The requirements are not onerous, but they are mandatory:

Transactional email -- confirmations, appointment reminders, account notices -- is exempt from CAN-SPAM's content requirements. But marketing email to physicians about a product or service is commercial email and must comply. The FTC's CAN-SPAM compliance guide covers each requirement in detail.

What about GDPR if you are targeting doctors outside the US?

If your HCP list includes physicians or other providers licensed in EU member states, GDPR applies to those records. The typical lawful basis for B2B prospecting email under GDPR is legitimate interests under Article 6(1)(f). To rely on it you need to conduct a legitimate interests assessment and be prepared to demonstrate that your interests are not overridden by the data subject's rights.

Practically, this means:

EmailAddress.ai's physician email data by specialty identifies whether records include international contacts, and the HCP data licensing documentation includes jurisdiction-level coverage notes.

What is the difference between legal HCP contact data and data you cannot buy?

The clearest way to understand the line: legal HCP contact data describes the provider in their professional role. Data you cannot legally buy describes a patient's health situation linked to an identifiable person.

Legal to buy and use for B2B marketing:

Not legal to buy for marketing (involves PHI or patient data):

CMS Medicare Part D prescribing data is publicly released annually by CMS and is legal to use. It shows aggregate prescribing volumes by NPI, not individual patient records. This is different from proprietary claims data obtained through a payer relationship, which carries different obligations.

Are there any industry-specific rules beyond federal law?

For pharmaceutical companies that are members of PhRMA, the PhRMA Code on Interactions with Healthcare Professionals is a voluntary industry standard. It governs meals, gifts, speaking fees, and consulting arrangements with physicians. It does not restrict email marketing or the purchase of HCP contact lists.

FDA promotional regulations apply to any email that makes claims about a prescription drug or medical device. These require fair balance (disclosure of risks alongside benefits), accurate indication statements, and -- for prescription drugs -- a brief summary or major statement. If your email is a product brochure or a promotional piece for an Rx drug, your regulatory or medical affairs team should review it before it goes out. If your email is an invitation to a medical education event, a conference announcement, or a clinical publication notice, these requirements apply differently or not at all depending on content.

For more detail on what outreach to physicians is and is not permissible, see the related guide: Can you email a doctor? HCP outreach compliance explained.

What makes an HCP email list compliant to use?

The list itself being legal to buy is only part of the picture. How you use it determines whether your outreach stays compliant. A compliant HCP email program looks like this:

G
Gautam
EmailAddress.ai

Gautam leads data and growth at EmailAddress.ai. The team has verified over 1.3 billion B2B and healthcare email addresses for pharma, health-tech, and B2B sales teams across 30+ countries.

EmailAddress.ai HCP Data: 10.17M NPI-Matched Contacts

Physician emails across 39 specialties, verified for deliverability and matched to the CMS NPI registry. Includes specialty, hospital affiliation, office phone, and state license. Refreshed monthly.

See HCP Data Coverage

Frequently asked questions

Does HIPAA prevent you from buying a physician email list?

No. HIPAA governs how covered entities (hospitals, health plans, healthcare clearinghouses) and their business associates handle protected health information. A pharma company or B2B vendor buying a list of physician professional contact details is not regulated by HIPAA in this context. A physician's work email, NPI number, specialty, and office address are professional data, not PHI.

Is it legal to cold email a doctor for B2B marketing purposes?

Yes, in the United States. Cold B2B email to healthcare professionals is governed primarily by CAN-SPAM, which requires a physical postal address, a working unsubscribe mechanism, no deceptive subject lines, and honoring opt-outs within 10 business days. As long as your email is commercial in nature and follows those requirements, it is legal to send.

What is the difference between HIPAA-protected data and physician contact data?

PHI is health information tied to an identifiable patient -- diagnoses, prescriptions, treatment records. A physician's own professional contact information -- their work email, NPI number, specialty, hospital affiliation -- is not patient data. It describes the provider, not a patient. Buying a list of physician professional contacts does not involve PHI and is not subject to HIPAA.

Do GDPR rules apply when emailing healthcare professionals in Europe?

Yes. If you are emailing physicians or other HCPs based in EU countries, GDPR applies. The typical lawful basis for B2B prospecting email is legitimate interests under Article 6(1)(f), but you must conduct a legitimate interests assessment and honor the right to object promptly. Some EU member states also have national ePrivacy rules that require opt-in for B2B email, stricter than the GDPR baseline.

Can you use physician email lists for pharmaceutical marketing?

Yes. Pharma companies routinely use physician email lists for medical education, conference invitations, product launch announcements, and field sales support. CAN-SPAM governs the email itself. For PhRMA member companies, the PhRMA Code governs gifts and payments but not email outreach. Promotional emails for prescription drugs are subject to FDA requirements around fair balance and indication accuracy.

What should you look for in a compliant HCP email list vendor?

Look for NPI-matched records (NPI is a permanent CMS-assigned identifier that verifies the provider is real and licensed), verified work emails rather than personal addresses, documented data sourcing that does not involve PHI, a stated refresh cadence, and field-level accuracy rates. EmailAddress.ai's HCP dataset covers 10.17 million healthcare professionals matched to the CMS NPI registry, with email deliverability verification applied across the full dataset.

What happens if a physician on your list unsubscribes?

Under CAN-SPAM you must honor the unsubscribe within 10 business days and cannot send further commercial email to that address. Suppress the address in your ESP and pass the suppression back to your data vendor so it is excluded from future list pulls. Recontacting a suppressed address is a CAN-SPAM violation and can result in FTC enforcement or private litigation.